Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Tenascin-C is a driver of inflammation in the DSS model of colitis

Journal article

MIDWOOD KIM., (2022), Matrix Biology Plus

FAS2FURIOUS: Moderate-throughput secreted expression of difficult recombinant proteins in Drosophila S2 cells

Journal article

MIDWOOD KIM. et al, (2022), Frontiers in Bioengineering and Biotechnology, section Synthetic Biology

Tenascin-C in fibrosis in multiple organs: translational implications

Journal article

MIDWOOD KIM. et al, (2022), Seminars in Cell and Developmental Biology

Tenascins: key players in tissue homeostasis and defence

Journal article

Midwood K., (2022), Frontiers in Immunology

Editorial: Tenascins - Key Players in Tissue Homeostasis and Defense

Journal article

MIDWOOD KIM., (2022), Frontiers in Immunology

Location, location, location: how the tissue microenvironment affects inflammation in RA.

Journal article

Buckley CD. et al, (2021), Nat Rev Rheumatol

Macrophages and extracellular matrix in breast cancer: partners in crime or protective allies?

Journal article

MIDWOOD KIM. and DELIGNE C., (2021), Frontiers in Oncology

Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritis

Journal article

MIDWOOD KIM. and SCHWENZER A., (2021), Journal of Clinical Immunology Insight

T and B Cell Responses to Common Tenascin-C Peptides in RA

Conference paper

Song J. et al, (2020), ARTHRITIS & RHEUMATOLOGY, 72

Matrix-targeting immunotherapy controls tumor growth and spread by switching macrophage phenotype

Journal article

MIDWOOD KIM., (2020), Cancer Immunology Research

Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosis

Journal article

Izadi D. et al, (2019), Science Advances

Load More